PRESS RELEASE published on 11/10/2023 at 06:30, 2 years 5 months ago Formycon hosts conference call on nine-month figures 2023 and presents at further investor conferences
PRESS RELEASE published on 10/10/2023 at 07:30, 2 years 6 months ago Formycon Ranibizumab Biosimilar FYB201/CIMERLI®1 achieved 25% market share2 in the United States
PRESS RELEASE published on 09/29/2023 at 07:30, 2 years 7 months ago Formycon and Fresenius Kabi announce European Medicines Agency Submission Acceptance of the Marketing Authorization Application for FYB202, an Ustekinumab Biosimilar Candidate
PRESS RELEASE published on 08/30/2023 at 07:30, 2 years 8 months ago Formycon reports successful first half of 2023
PRESS RELEASE published on 08/29/2023 at 07:30, 2 years 8 months ago Formycon announces File Acceptance for FYB203, a biosimilar candidate to Eylea®1 (aflibercept), by the U.S. Food and Drug Administration (FDA)
PRESS RELEASE published on 08/23/2023 at 07:30, 2 years 8 months ago Formycon hosts conference call on financial and earnings position for H1 2023
PRESS RELEASE published on 08/21/2023 at 13:42, 2 years 8 months ago Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE published on 08/07/2023 at 08:00, 2 years 8 months ago Formycon and Fresenius Kabi secure U.S. License Date for proposed Ustekinumab Biosimilar
PRESS RELEASE published on 07/26/2023 at 07:30, 2 years 9 months ago Formycon reports on the regular Annual General Meeting
PRESS RELEASE published on 06/29/2023 at 07:30, 2 years 10 months ago Formycon announces submission of the biologics license application (BLA) for FYB203, an aflibercept biosimilar candidate to the U.S. Food and Drug Administration (FDA)
Published on 05/06/2026 at 09:01, 1 hour 27 minutes ago Apex Widens and Extends Newly Discovered Zone with Significant NdPr Enrichment (>30%)
Published on 05/06/2026 at 02:17, 8 hours 11 minutes ago Troubadour Announces Share Consolidation and Effective Date
Published on 05/06/2026 at 02:00, 8 hours 28 minutes ago Vanta Announces Closing of First Tranche of Private Placement and Debt Settlement
Published on 05/06/2026 at 02:00, 8 hours 28 minutes ago Alset AI Announces Shares for Debt Transaction
Published on 05/06/2026 at 10:00, 28 minutes ago 2026 Pacific Ocean International Festival of Rock Balancing and Arts Holds Grand Opening at Qixingtan Scenic Area on May 1st
Published on 05/06/2026 at 10:00, 28 minutes ago Mallia Therapeutics Announces Publication and Congress Presentation on Accelerated Wound Healing with sCD83
Published on 05/06/2026 at 10:00, 28 minutes ago MAKTEK Eurasia 2026 positions Türkiye as a manufacturing hub
Published on 05/06/2026 at 09:35, 53 minutes ago Huawei SPN Helps Yunnan Power Grid Build a Next-Gen High-Speed Bearer Network
Published on 05/06/2026 at 10:09, 19 minutes ago Guillemot Corporation : Information regarding the total number of voting rights and shares 30/04/2026
Published on 05/06/2026 at 08:42, 1 hour 46 minutes ago Disclosure of shares outstanding and voting rights - 06.05.2026
Published on 05/05/2026 at 19:00, 15 hours 28 minutes ago Combined General Meeting of Air Liquide Shareholders of May 5, 2026
Published on 05/05/2026 at 18:03, 16 hours 25 minutes ago Aéroports de Paris SA - Shares and voting rights as of 30 April 2026
